Carson Wealth (CWM LLC)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-83	Closed	-$1K	–	5052
2024 Q1	$1K	Buy	83 +11	+15%	+$169	﹤0.01%	4269
2023 Q4	$1K	Sell	72 -57	-44%	-$727	﹤0.01%	4084
2023 Q3	$2K	Hold	129	–	–	﹤0.01%	3893
2023 Q2	$2K	Hold	129	–	–	﹤0.01%	3872
2023 Q1	$2K	Hold	129	–	–	﹤0.01%	3735
2022 Q4	$2K	Hold	129	–	–	﹤0.01%	3656
2022 Q3	$2K	Hold	129	–	–	﹤0.01%	3572
2022 Q2	$2K	Buy	129 +60	+87%	+$662	﹤0.01%	3450
2022 Q1	$1K	Buy	69 +45	+188%	+$383	﹤0.01%	3451
2021 Q4	$0	Buy	+24	New	+$451	﹤0.01%	3686

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Carson Wealth (CWM LLC)'s DCPH Position: Q2 2024 in Review

Carson Wealth (CWM LLC) sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 83 shares — an estimated $1K sold.

Carson Wealth (CWM LLC) first reported a position in DCPH in Q4 2021 and held it in 10 quarters. The position peaked at $2K in Q3 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Carson Wealth (CWM LLC) reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 83 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1K.
Carson Wealth (CWM LLC) first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
Carson Wealth (CWM LLC)'s Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q3 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2024, filed 10 Jul 2024.